Nutex Health Inc.: Form 10-K/A for the period ended Dec 31, 2018
Filed with the SEC on Apr 17, 2019 and accepted by EDGAR at Apr 17, 2019, 14:09 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2018-01-01 to 2018-12-31 | $60.2k | us-gaap:Revenues |
| Cost of revenue | 12 months2018-01-01 to 2018-12-31 | $31.1k | us-gaap:CostOfRevenue |
| Gross profit | 12 months2018-01-01 to 2018-12-31 | $29.1k | us-gaap:GrossProfit |
| Operating income | 12 months2018-01-01 to 2018-12-31 | −$1.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2018-01-01 to 2018-12-31 | $642.1k | us-gaap:InterestExpense |
| Net income | 12 months2018-01-01 to 2018-12-31 | −$2.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2018-01-01 to 2018-12-31 | −$0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2018-01-01 to 2018-12-31 | −$765.5k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2018-12-31 | $369 | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $42.3k | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $2.6m | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $1.4m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2018-12-31 | $1.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001607062-19-000163. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.